Avenue Therapeutics shares owned by UBS Group
Quarter-by-quarter ownership of Avenue Therapeutics (ATXI) shares owned by UBS Group
from 13F filings
Historical chart of UBS Group investment in Avenue Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Avenue Therapeutics held by UBS Group consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Avenue Therapeutics by UBS Group
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2023-12-31 | $173 | 1.1k | 0.16 |
| 2022-12-31 | $1.4k | 1.2k | 1.16 |
| 2022-09-30 | $11k | 1.1k | 9.67 |